West China Hospital: Lung Neoplasms trials

The registry lists 11 Lung Neoplasms studies with West China Hospital as lead sponsor. 5 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 3No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• MDT-Based Umbrella Decision Model for Geriatric Lung Cancer PatientsRecruitingNCT07509333Not applicable
• Zusanli (ST36) Electroacupuncture Treatment for Neoadjuvant Immunotherapy in Non-Small Cell Lung CancerRecruitingNCT07076836Not applicable
• Neoadjuvant Ensartinib in ALK Positive Resectable Stage II to III Non-Small Cell Lung CancerNot yet recruitingNCT06779539Phase 2
• Neoadjuvant Chemoimmunotherapy in Stage IIIA- N2IIIB Non-small Cell Lung CancerNot yet recruitingNCT06394427
• Assessment System of Sarcopenia in Lung Cancer PatientsRecruitingNCT06327594
• Neoadjuvant Chemotherapy and Tilelizumab in Stage III（cTNM-IIIA.IIIB）Non-small-cell Lung CancerStatus unknownNCT04865705Phase 2
• Reduced Dissemination of Tumor Cells With Primary Ligation of the Vein in Patients With Lung CancerStatus unknownNCT03436329Not applicable
• A Study to Evaluate Clinical Characteristics of Lung Cancer in Patients With Surgeries and Adjuvant TherapiesCompletedNCT03421093
• Dynamic Monitoring Circulating Tumor DNA in Surgical Patients With Lung CancerStatus unknownNCT03317080
• Apatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLCStatus unknownNCT03201146Phase 1/2
• Comparison Between Wedge Resection and Segmentectomy for Ground Glass Opacity- Dominant Stage IA NSCLCStatus unknownNCT02718365Not applicable